The Washington Post @washingtonpost
The company plans to apply for approval of the vaccine before year’s end, with the hope that the shot could be the first vaccine to help protect infants against RSV — respiratory syncytial virus — as soon as next winter. https://t.co/cwrQcnh6DU — PolitiTweet.org